AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

AFC-HD AMS Life Science Balance Sheet

Financials in millions JPY. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	11,342	12,172	11,182	10,377	9,222	4,725
Cash & Short-Term Investments	11,342	12,172	11,182	10,377	9,222	4,725
Cash Growth	-1.27%	8.85%	7.76%	12.52%	95.17%	6.49%
Receivables	3,014	2,792	2,828	2,563	2,184	2,128
Inventory	7,433	5,981	4,362	3,728	3,851	2,995
Other Current Assets	1,018	1,149	1,503	457	595	161
Total Current Assets	22,807	22,094	19,875	17,125	15,852	10,009
Property, Plant & Equipment	20,499	19,416	17,144	15,922	16,011	7,659
Long-Term Investments	3,213	2,857	2,558	2,808	2,115	640
Goodwill	2,125	2,349	1,289	1,338	1,491	-
Other Intangible Assets	151	167	92	118	161	162
Long-Term Deferred Tax Assets	-	146	112	35	120	77
Other Long-Term Assets	3	1	1	2	2	1
Total Assets	48,798	47,030	41,071	37,348	35,752	18,548
Accounts Payable	3,620	3,586	3,265	3,414	2,966	2,009
Accrued Expenses	300	188	170	152	196	170
Short-Term Debt	10,523	9,078	7,914	6,816	3,962	2,762
Current Portion of Long-Term Debt	-	519	303	182	1,027	103
Current Income Taxes Payable	323	506	368	175	646	196
Other Current Liabilities	3,132	3,745	2,834	2,479	3,005	964
Total Current Liabilities	17,898	17,622	14,854	13,218	11,802	6,204
Long-Term Debt	13,768	13,293	11,319	10,136	9,691	1,082
Long-Term Deferred Tax Liabilities	-	229	258	265	298	15
Other Long-Term Liabilities	1,035	908	493	285	327	149
Total Liabilities	33,734	33,074	27,915	24,904	23,092	8,084
Common Stock	2,131	2,131	2,131	2,131	2,131	2,131
Additional Paid-In Capital	2,623	2,650	2,638	2,640	2,438	2,195
Retained Earnings	10,462	9,415	8,589	7,880	7,420	6,238
Treasury Stock	-279	-275	-353	-305	-141	-59
Comprehensive Income & Other	-16	11	103	92	69	-41
Total Common Equity	14,921	13,932	13,108	12,438	11,917	10,464
Minority Interest	143	24	48	6	743	-
Shareholders' Equity	15,064	13,956	13,156	12,444	12,660	10,464
Total Liabilities & Equity	48,798	47,030	41,071	37,348	35,752	18,548
Total Debt	24,291	22,890	19,536	17,134	14,680	3,947
Net Cash (Debt)	-12,949	-10,718	-8,354	-6,757	-5,458	778
Net Cash Growth	-	-	-	-	-	116.11%
Net Cash Per Share	-920.45	-762.76	-594.48	-478.56	-387.93	55.32
Filing Date Shares Outstanding	14.06	14.06	13.97	14.04	14.19	13.85
Total Common Shares Outstanding	14.06	14.06	13.97	14.04	14.19	14.06
Working Capital	4,909	4,472	5,021	3,907	4,050	3,805
Book Value Per Share	1061.27	990.63	938.19	886.21	839.75	744.04
Tangible Book Value	12,645	11,416	11,727	10,982	10,265	10,302
Tangible Book Value Per Share	899.39	811.73	839.35	782.47	723.34	732.52
Order Backlog	-	933.61	891.23	718.94	714.19	790.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.